Dianthus Therapeutics Stock Forecast - Relative Strength Index
| DNTH Stock | 36.72 0.00 0.00% |
Dianthus Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Dianthus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of Dianthus Therapeutics' share price is above 70 as of 5th of January 2026 suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Dianthus, making its price go up or down. Momentum 75
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.86) | EPS Estimate Current Year (3.74) | EPS Estimate Next Year (3.87) | Wall Street Target Price 63.0475 | EPS Estimate Current Quarter (0.90) |
Using Dianthus Therapeutics hype-based prediction, you can estimate the value of Dianthus Therapeutics from the perspective of Dianthus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Dianthus Therapeutics using Dianthus Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Dianthus using crowd psychology based on the activity and movement of Dianthus Therapeutics' stock price.
Dianthus Therapeutics Implied Volatility | 1.34 |
Dianthus Therapeutics' implied volatility exposes the market's sentiment of Dianthus Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Dianthus Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Dianthus Therapeutics stock will not fluctuate a lot when Dianthus Therapeutics' options are near their expiration.
Dianthus Therapeutics after-hype prediction price | USD 37.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Dianthus Therapeutics to cross-verify your projections. Open Interest Against 2026-02-20 Dianthus Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Dianthus Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Dianthus Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Dianthus Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Dianthus Therapeutics' open interest, investors have to compare it to Dianthus Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Dianthus Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Dianthus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Dianthus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dianthus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dianthus using various technical indicators. When you analyze Dianthus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 75.47 | 75.47 |
| Check Dianthus Therapeutics Volatility | Backtest Dianthus Therapeutics | Information Ratio |
Dianthus Therapeutics Trading Date Momentum
| On January 05 2026 Dianthus Therapeutics was traded for 36.72 at the closing time. The top price for the day was 41.53 and the lowest listed price was 36.72 . There was no trading activity during the period 0.0. Lack of trading volume on January 5, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
| Compare Dianthus Therapeutics to competition |
Other Forecasting Options for Dianthus Therapeutics
For every potential investor in Dianthus, whether a beginner or expert, Dianthus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dianthus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dianthus. Basic forecasting techniques help filter out the noise by identifying Dianthus Therapeutics' price trends.Dianthus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dianthus Therapeutics stock to make a market-neutral strategy. Peer analysis of Dianthus Therapeutics could also be used in its relative valuation, which is a method of valuing Dianthus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dianthus Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Dianthus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Dianthus Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dianthus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By undertsting and applying Dianthus Therapeutics stock market strength indicators, traders can identify Dianthus Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 0.12 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 39.13 | |||
| Day Typical Price | 38.32 | |||
| Market Facilitation Index | 4.81 | |||
| Price Action Indicator | (2.41) | |||
| Relative Strength Index | 75.47 |
Dianthus Therapeutics Risk Indicators
The analysis of Dianthus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dianthus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dianthus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.09 | |||
| Semi Deviation | 2.51 | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.7 | |||
| Downside Variance | 6.92 | |||
| Semi Variance | 6.31 | |||
| Expected Short fall | (2.62) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Dianthus Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dianthus Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dianthus Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dianthus Therapeutics Stock:Check out Historical Fundamental Analysis of Dianthus Therapeutics to cross-verify your projections. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dianthus Therapeutics. If investors know Dianthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.50) | Revenue Per Share | Quarterly Revenue Growth (0.82) | Return On Assets | Return On Equity |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dianthus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dianthus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dianthus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.